213 related articles for article (PubMed ID: 15187777)
21. Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
Greene CM; Miller SD; Carroll T; McLean C; O'Mahony M; Lawless MW; O'Neill SJ; Taggart CC; McElvaney NG
J Inherit Metab Dis; 2008 Feb; 31(1):21-34. PubMed ID: 18193338
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary epithelial expression of human alpha1-antitrypsin in transgenic mice results in delivery of alpha1-antitrypsin protein to the interstitium.
Dhami R; Zay K; Gilks B; Porter S; Wright JL; Churg A
J Mol Med (Berl); 1999 Apr; 77(4):377-85. PubMed ID: 10353442
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of intracellular degradation increases secretion of a mutant form of alpha1-antitrypsin associated with profound deficiency.
Novoradovskaya N; Lee J; Yu ZX; Ferrans VJ; Brantly M
J Clin Invest; 1998 Jun; 101(12):2693-701. PubMed ID: 9637703
[TBL] [Abstract][Full Text] [Related]
24. Alpha-1-antitrypsin deficiency: a new paradigm for hepatocellular carcinoma in genetic liver disease.
Rudnick DA; Perlmutter DH
Hepatology; 2005 Sep; 42(3):514-21. PubMed ID: 16044402
[TBL] [Abstract][Full Text] [Related]
25. Atraumatic loss of a kidney in a patient with alpha1-antitrypsin deficiency.
Randers E; Jønler M; Lund AM; Danielsen H
Nephron; 1998 Sep; 80(1):71-5. PubMed ID: 9730708
[TBL] [Abstract][Full Text] [Related]
26. Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency.
Fuchs SI; Schwerk N; Pittschieler K; Ahrens F; Baden W; Bals R; Fähndrich S; Gleiber W; Griese M; Hülskamp G; Köhnlein T; Reckling L; Rietschel E; Staab D; Gappa M
Respir Med; 2016 Jul; 116():93-9. PubMed ID: 27296827
[TBL] [Abstract][Full Text] [Related]
27. Discovery of an inhibitor of Z-alpha1 antitrypsin polymerization.
Berthelier V; Harris JB; Estenson KN; Baudry J
PLoS One; 2015; 10(5):e0126256. PubMed ID: 25961288
[TBL] [Abstract][Full Text] [Related]
28. Compound heterozygosity for alpha-1-antitrypsin (S(iiyama) and QO(clayton)) in an Oriental patient.
Miyahara N; Seyama K; Sato T; Fukuchi Y; Eda R; Takeyama H; Harada M
Intern Med; 2001 Apr; 40(4):336-40. PubMed ID: 11334395
[TBL] [Abstract][Full Text] [Related]
29. [Severe alpha 1-antitrypsin deficiency: clinical observations of 21 patients].
Dürst A; Grob PJ
Schweiz Med Wochenschr; 1978 Dec; 108(51):2040-6. PubMed ID: 310577
[TBL] [Abstract][Full Text] [Related]
30. Alpha1-Antitrypsin Deficiency: A Cause of Chronic Liver Disease.
Manne V; Kowdley KV
Clin Liver Dis; 2020 Aug; 24(3):483-492. PubMed ID: 32620284
[TBL] [Abstract][Full Text] [Related]
31. Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.
Dickens JA; Lomas DA
Drug Des Devel Ther; 2011; 5():391-405. PubMed ID: 21966212
[TBL] [Abstract][Full Text] [Related]
32. Post-Transcriptional Regulation of Alpha One Antitrypsin by a Proteasome Inhibitor.
Rao L; Xu Y; Reineke LC; Bhattacharya A; Tyryshkin A; Shin JN; Eissa NT
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560429
[TBL] [Abstract][Full Text] [Related]
33. Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.
Corda L; Medicina D; La Piana GE; Bertella E; Moretti G; Bianchi L; Pinelli V; Savoldi G; Baiardi P; Facchetti F; Gatta N; Annesi-Maesano I; Balbi B
Respiration; 2011; 82(5):418-25. PubMed ID: 21474916
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology and treatment of alpha 1-antitrypsin deficiency.
MacDonald JL; Johnson CE
Am J Health Syst Pharm; 1995 Mar; 52(5):481-9;quiz 544-5. PubMed ID: 7606551
[TBL] [Abstract][Full Text] [Related]
35. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
[TBL] [Abstract][Full Text] [Related]
36. The current status of alpha-1-antityrpsin, a protease inhibitor, in gastrointestinal disease.
Sharp HL
Gastroenterology; 1976 Apr; 70(4):611-21. PubMed ID: 767197
[TBL] [Abstract][Full Text] [Related]
37. Alpha-1-antitrypsin deficiency: importance of proteasomal and autophagic degradative pathways in disposal of liver disease-associated protein aggregates.
Perlmutter DH
Annu Rev Med; 2011; 62():333-45. PubMed ID: 20707674
[TBL] [Abstract][Full Text] [Related]
38. Alpha-1-antitrypsin deficiency: an overview of recent advances.
El Hazmi MA
Saudi J Gastroenterol; 1996 Sep; 2(3):113-9. PubMed ID: 19864818
[TBL] [Abstract][Full Text] [Related]
39. Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency.
Pye A; Turner AM
Expert Opin Investig Drugs; 2019 Oct; 28(10):891-902. PubMed ID: 31550938
[No Abstract] [Full Text] [Related]
40. Twenty years of polymers: a personal perspective on alpha-1 antitrypsin deficiency.
Lomas DA
COPD; 2013 Mar; 10 Suppl 1():17-25. PubMed ID: 23527623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
